Browse our collection of papers in
Ansoff analysis

C/B/3259. Strategic capability of GlaxoSmithKline

WORDS:
1300
DATE:
2010
PRICE:
19.99 GBP

The paper examines the sources of competitive advantage used by GlaxoSmithKline (GSK) identifying their core competences and capabilities, analyzing the company’s product development strategy using the Ansoff matrix, and categorizing GSK stakeholders on the basis of the Mendelow matrix.

 

KEYWORDS: Strategic capability, GlaxoSmithKline, GSK, Competitive Advantage, Ansoff Matrix, Mendelow Matrix,

 
Other Papers On: GlaxoSmithKline (GSK)
Other Papers On: Strategic capability
Other Papers On: Ansoff analysis